Literatur
Berges R (2008) Epidemiologie des benignen Prostatasyndroms: assoziierte Risiken und Versorgungsdaten bei deutschen Männern über 50. Urologe A 47(2): 141–148
Berges R, Dreikorn K, Höfner K et al (2003) Leitlinien der Deutschen Urologen zur Diagnostik des benignen Prostatasyndroms (BPS). Urologe A 42(4): 584–590
Barry MJ, Cockett AT, Holtgrewe HL et al (1993) Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 150: 351–358
Hald T (1989) Urodynamics in benign protatic hyperplasia: a survey. Prostate 2(Suppl): 69–77
Berges R, Dreikorn K, Höfner K et al (2003) Leitlinien der Deutschen Urologen zur Therapie des benignen Prostatasyndroms (BPS). Urologe A 42(5): 722–738
Roehrborn C, McConnell J, Barry M et al (2003) Guideline of the Management of benign prostatic hyperplasia (BPH). 2003 [cited; Chapter 3:Appendix 1-56] Availble from: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=bph
Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation oft the prostate versus open prostatectomy for prostates greater than 100 grams:5-year follow-up results of a randomised clinical trial. Eur Urol 53(1): 160–166
Bouchier-Hayes D (2007) Photoselective vaporization of the prostate – towards a new standard. Prostate Cancer Prostatic Dis 10: 10–14
Monga M (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Int Braz J Urol 34(4): 517
Brikowski TH, Lotan Y, Pearöe MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA 105: 9841–1846
Taylor EN, Curhan GC (2008) Fructose consumption and the risk of kidney stones. Kidney Int 73(2): 207–212
Vitart V, Rudan I, Hayward C et al (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate Excretion and gout. Nat Genet 40(4): 437–442
Pedro RN, Hinck B, Hendlin K et al (2008) Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J Urol 179: 2244
Kobayashi M, Naya Y, Kino M et al (2008) Low dose tamsulosin for stone explusion after extracorporal shock wave lithotripsy: efficacy in Japanese male patients with urethral stone. Int J Urol 15(6): 495–498
Beddingfield R, Pedro RN, Hinck B et al (2009) Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol 181(1): 170–176
Bensalah K, Pearle M, Lotan Y (2008) Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal uretreal stones. Eur Urol 53(2): 411–418
Rini BI, Halabi S, Rosenberg JE et al (2008) Bevacizumab plus Interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206. J Clin Oncol 26: 5422–5428
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Additional information
Nächstes Urologie-Updateseminar:
Aufgrund der großen Resonanz ist schon jetzt das 3. Uro Update geplant. Es wird am 26./27. Februar 2010 wieder in Düsseldorf stattfinden.
Rights and permissions
About this article
Cite this article
Ayazpoor, U. Urologie-Updateseminar UroUpdate. Urologe 48, 790–792 (2009). https://doi.org/10.1007/s00120-009-2026-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-009-2026-0